Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Mar 1;101(5):921–926. doi: 10.1172/JCI2860

HLA transgenic mice as humanized mouse models of disease and immunity.

V Taneja 1, C S David 1
PMCID: PMC508640  PMID: 9486959

Full Text

The Full Text of this article is available as a PDF (2.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann D. M., Douek D. C., Frater A. J., Hetherington C. M., Inoko H., Elliott J. I. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med. 1995 Mar 1;181(3):867–875. doi: 10.1084/jem.181.3.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bagavant H., Fusi F. M., Baisch J., Kurth B., David C. S., Tung K. S. Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine. Biol Reprod. 1997 Mar;56(3):764–770. doi: 10.1095/biolreprod56.3.764. [DOI] [PubMed] [Google Scholar]
  3. Bradley D. S., Nabozny G. H., Cheng S., Zhou P., Griffiths M. M., Luthra H. S., David C. S. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest. 1997 Nov 1;100(9):2227–2234. doi: 10.1172/JCI119760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cammarota G., Scheirle A., Takacs B., Doran D. M., Knorr R., Bannwarth W., Guardiola J., Sinigaglia F. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature. 1992 Apr 30;356(6372):799–801. doi: 10.1038/356799a0. [DOI] [PubMed] [Google Scholar]
  5. Cheng S., Baisch J., Krco C., Savarirayan S., Hanson J., Hodgson K., Smart M., David C. Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in transgenic mice. Eur J Immunogenet. 1996 Feb;23(1):15–20. doi: 10.1111/j.1744-313x.1996.tb00260.x. [DOI] [PubMed] [Google Scholar]
  6. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 1991 Sep 6;66(5):1051–1066. doi: 10.1016/0092-8674(91)90448-8. [DOI] [PubMed] [Google Scholar]
  7. Fugger L., Michie S. A., Rulifson I., Lock C. B., McDevitt G. S. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6151–6155. doi: 10.1073/pnas.91.13.6151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fukui Y., Nishimura Y., Iwanga T., Kimura A., Inamitsu T., Hanaoka Y., Kitigawa T., Sasazuki T. Glycosuria and insulitis in NOD mice expressing the HLA-DQw6 molecule. J Immunogenet. 1989 Dec;16(6):445–453. doi: 10.1111/j.1744-313x.1989.tb00493.x. [DOI] [PubMed] [Google Scholar]
  9. Gonzalez-Gay M. A., Nabozny G. H., Bull M. J., Zanelli E., Douhan J., 3rd, Griffiths M. M., Glimcher L. H., Luthra H. S., David C. S. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J Exp Med. 1994 Oct 1;180(4):1559–1564. doi: 10.1084/jem.180.4.1559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gonzalez-Gay M. A., Zanelli E., Khare S. D., Krco C. J., Zhou P., Inoko H., Griffiths M. M., Luthra H. S., David C. S. Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol. 1996 Sep 15;50(1):54–60. doi: 10.1016/0198-8859(96)00123-1. [DOI] [PubMed] [Google Scholar]
  11. Gonzalez-Gay M. A., Zanelli E., Krco C. J., Nabozny G. H., Hanson J., Griffiths M. M., Luthra H. S., David C. S. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics. 1995;42(1):35–40. doi: 10.1007/BF00164985. [DOI] [PubMed] [Google Scholar]
  12. Hammer R. E., Maika S. D., Richardson J. A., Tang J. P., Taurog J. D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990 Nov 30;63(5):1099–1112. doi: 10.1016/0092-8674(90)90512-d. [DOI] [PubMed] [Google Scholar]
  13. Ito K., Bian H. J., Molina M., Han J., Magram J., Saar E., Belunis C., Bolin D. R., Arceo R., Campbell R. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med. 1996 Jun 1;183(6):2635–2644. doi: 10.1084/jem.183.6.2635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Khare S. D., Hansen J., Luthra H. S., David C. S. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest. 1996 Dec 15;98(12):2746–2755. doi: 10.1172/JCI119100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Khare S. D., Luthra H. S., David C. S. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med. 1995 Oct 1;182(4):1153–1158. doi: 10.1084/jem.182.4.1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kong Y. C., Lomo L. C., Motte R. W., Giraldo A. A., Baisch J., Strauss G., Hämmerling G. J., David C. S. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med. 1996 Sep 1;184(3):1167–1172. doi: 10.1084/jem.184.3.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lawrance S. K., Karlsson L., Price J., Quaranta V., Ron Y., Sprent J., Peterson P. A. Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice. Cell. 1989 Aug 11;58(3):583–594. doi: 10.1016/0092-8674(89)90439-x. [DOI] [PubMed] [Google Scholar]
  18. Matsushita S., Nishi T., Oiso M., Yamaoka K., Yone K., Kanai T., Nishimura Y. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int Immunol. 1996 May;8(5):757–764. doi: 10.1093/intimm/8.5.757. [DOI] [PubMed] [Google Scholar]
  19. Nabozny G. H., Baisch J. M., Cheng S., Cosgrove D., Griffiths M. M., Luthra H. S., David C. S. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med. 1996 Jan 1;183(1):27–37. doi: 10.1084/jem.183.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Neeno T., Krco C. J., Harders J., Baisch J., Cheng S., David C. S. HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens: identification of antigenic epitopes. J Immunol. 1996 May 1;156(9):3191–3195. [PubMed] [Google Scholar]
  21. Nishimura Y., Iwanaga T., Inamitsu T., Yanagawa Y., Yasunami M., Kimura A., Hirokawa K., Sasazuki T. Expression of the human MHC, HLA-DQW6 genes alters the immune response in C57BL/6 mice. J Immunol. 1990 Jul 1;145(1):353–360. [PubMed] [Google Scholar]
  22. Patel S. D., Cope A. P., Congia M., Chen T. T., Kim E., Fugger L., Wherrett D., Sonderstrup-McDevitt G. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8082–8087. doi: 10.1073/pnas.94.15.8082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Raju R., Munn S. R., David C. S. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice. Hum Immunol. 1997 Nov;58(1):21–29. doi: 10.1016/s0198-8859(97)00212-7. [DOI] [PubMed] [Google Scholar]
  24. Rosloniec E. F., Brand D. D., Myers L. K., Whittington K. B., Gumanovskaya M., Zaller D. M., Woods A., Altmann D. M., Stuart J. M., Kang A. H. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med. 1997 Mar 17;185(6):1113–1122. doi: 10.1084/jem.185.6.1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Strauss G., Vignali D. A., Schönrich G., Hämmerling G. J. Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice. Immunogenetics. 1994;40(2):104–108. [PubMed] [Google Scholar]
  26. Taneja V., Hansen J., Smart M., Griffiths M., Luthra H., David C. S. Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines. Int Immunol. 1997 Aug;9(8):1213–1219. doi: 10.1093/intimm/9.8.1213. [DOI] [PubMed] [Google Scholar]
  27. Vignali D. A., Moreno J., Schiller D., Hämmerling G. J. Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules. J Exp Med. 1992 Apr 1;175(4):925–932. doi: 10.1084/jem.175.4.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wicker L. S., Chen S. L., Nepom G. T., Elliott J. F., Freed D. C., Bansal A., Zheng S., Herman A., Lernmark A., Zaller D. M. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest. 1996 Dec 1;98(11):2597–2603. doi: 10.1172/JCI119079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Woods A., Chen H. Y., Trumbauer M. E., Sirotina A., Cummings R., Zaller D. M. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med. 1994 Jul 1;180(1):173–181. doi: 10.1084/jem.180.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yamamoto K., Fukui Y., Esaki Y., Inamitsu T., Sudo T., Yamane K., Kamikawaji N., Kimura A., Sasazuki T. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice. J Exp Med. 1994 Jul 1;180(1):165–171. doi: 10.1084/jem.180.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yeung R. S., Penninger J. M., Kündig T. M., Law Y., Yamamoto K., Kamikawaji N., Burkly L., Sasazuki T., Flavell R., Ohashi P. S. Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function. J Exp Med. 1994 Nov 1;180(5):1911–1920. doi: 10.1084/jem.180.5.1911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zanelli E., Gonzalez-Gay M. A., David C. S. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today. 1995 Jun;16(6):274–278. doi: 10.1016/0167-5699(95)80181-2. [DOI] [PubMed] [Google Scholar]
  33. Zanelli E., Krco C. J., Baisch J. M., Cheng S., David C. S. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1814–1819. doi: 10.1073/pnas.93.5.1814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zanelli E., Krco C. J., David C. S. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J Immunol. 1997 Apr 1;158(7):3545–3551. [PubMed] [Google Scholar]
  35. Zhou P., Anderson G. D., Savarirayan S., Inoko H., David C. S. Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice. J Immunol. 1991 Feb 1;146(3):854–859. [PubMed] [Google Scholar]
  36. Zhou P., Smart M. K., Cheng S., Savarirayan S., Inoko H., David C. S. HLA-DQ beta chain can present mouse endogenous provirus MTV-9 product and clonally delete Tcr V beta 5+ and V beta 11+ T cells in transgenic mice. Immunogenetics. 1992;35(4):219–223. doi: 10.1007/BF00166826. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES